ASCO 2026: ADC and In Vivo CAR-T Trends in Oncology
What are the biggest trends shaping oncology investment and drug development in 2026? We sat...
ImCheck ex-CEO Pierre d’Epenoux talks Fundraising, France and Oncology’s Next Wave | E60
After ImCheck’s inception in 2015, Pierre took the helm through clinical development and guided the...
Personalized Cancer Vaccines and Oncolytic Viruses: The Next Generation of Cancer Immunotherapy
For decades, cancer vaccines have promised much and delivered little. Early “off-the-shelf” approaches struggled to...
Alessandro Riva, Transgene | Cancer Vaccines, Oncolytic Viruses | E50
Founded in 1979, Transgene has transformed itself into a leading personalized cancer vaccine player. Alessandro...
